Associate Director Forecasting & Valuation, Portfolio Strategy

Immunocore; Oxford; On-site; GBP 120,000 - 180,000; Full time

Job summary

Immunocore, based in Oxford, seeks a senior leader to define and drive forecasting, valuation strategy, and portfolio analytics to support our portfolio and corporate objectives.

You will serve as internal SME for forecasting and valuation, develop patient-based forecasts and DCF models for pipeline assets, build robust scenario analyses, and present clear outputs to senior leadership to inform strategic decisions.

Qualifications

• Bachelor’s degree in life sciences with 14+ years of relevant experience or equivalent.
• Experience in biotech/pharma required, via industry, banking, or consultancy roles.
• Experience in oncology essential; experience in additional disease areas desirable.
• Business or financial qualification an advantage but not essential.
• Excellent analytical abilities, including experience performing very complex competitor and market opportunity analysis in the biopharma industry.
• High level of financial literacy, including the ability to build DCF-valuation models and to design new modelling approaches where no precedent exists.
• Ability to collate and structure data from multiple sources to form a clear narrative and distil key issues.
• Strong understanding of the pharma/biotech industry – technical, clinical, and commercial knowledge.
• Strong communication skills – ability to present analysis and justify assumptions to senior leadership, and to influence, negotiate and persuade on difficult and contested concepts.
• Strong project management abilities; able to manage multiple workstreams simultaneously in a fast-paced environment.
• Experience contributing to company-level strategy, corporate valuation, investor relations and/or business development activity.
• Track record of improving processes, tools or platforms, including adoption of new technologies (e.g. AI-enabled modelling and analysis).

Responsibilities

• Develop and build patient-based forecasts and DCF valuation models to support investment decisions and company valuation.
• Triangulate data from multiple primary and secondary sources to help develop holistic package of baseline assumptions for asset valuation, resolving conflicting evidence and exercising independent judgement where data is limited or ambiguous.
• Build patient-based revenue forecasts and DCF valuation models for pipeline assets, selecting and, where required, creating fit-for-purpose modelling approaches.
• Proactively build trusted partnerships with key business partners across development, clinical, finance, commercial and business development.
• Influence, negotiate and build alignment among senior cross-functional stakeholders where assumptions, evidence or valuation conclusions are complex, uncertain or contested.
• Develop sensitivity and scenario analyses to characterise key forecast drivers and key risks for senior leadership.
• Develop clear summaries of model outputs, conclusions and implications for decision making and present to senior leadership.
• Drive delivery of the corporate valuation, ensuring assumptions are robust, well-evidenced and clearly documented.
• Support Investor Relations with guidance on sales forecasts for external communication.
• Lead complex cross-functional forecasting, valuation and portfolio planning initiatives, coordinating senior stakeholders and driving alignment on key business decisions.
• Develop comparative valuation analyses that position Immunocore’s portfolio against competitors to inform portfolio decisions and the external valuation narrative.
• Apply valuation metrics in portfolio-level scenario planning, quantifying the trade-offs between investment options to inform prioritisation and resource allocation decisions.
• Support Business Development by valuing licensing and partnering opportunities and outlining key sensitivities.
• Establish and maintain best-practice methodologies, governance and quality standards for forecasting and valuation activities.
• Lead the continued evolution of the forecasting and valuation platform, improving the approach and tools, in line with the agreed analytics strategy.
• Identify, evaluate and implement AI and other novel tools and data sources to build more complex models in less time, improve forecast accuracy and automate routine analyses, freeing capacity for higher-value strategic work.
• Act as internal champion for forecasting and valuation methods — validating outputs, defining where AI-assisted analysis is and is not appropriate, building stakeholder confidence in the results, and sharing best practice with colleagues across Portfolio Strategy and partner functions.

Skills

forecasting and valuation strategy

DCF valuation models

AI-enabled modelling and analysis

cross-functional forecasting

portfolio analytics

Education

Bachelor’s degree in life sciences & 14+ years of relevant experience or equivalent experience

Job description

Location of role

Oxford, UK

Department

Development Strategy

Key Responsibilities

The main purpose of this role is to define and drive the forecasting and valuation strategy, roadmap, standards and governance framework to support Immunocore's portfolio and corporate objectives.

Serve as Immunocore's internal subject matter expert and adviser for forecasting, valuation and portfolio analytics.

Leverage primary and secondary research findings and collaborate with key business partners to ensure these models reflect a robust understanding of market dynamics and emerging product profile

Key Responsibilities

Develop and build patient-based forecasts and DCF valuation models to support investment decisions and company valuation

• Triangulate data from multiple primary and secondary sources to help develop holistic package of baseline assumptions for asset valuation, resolving conflicting evidence and exercising independent judgement where data is limited or ambiguous


• Build patient-based revenue forecasts and DCF valuation models for pipeline assets, selecting and, where required, creating fit-for-purpose modelling approaches


• Proactively build trusted partnerships with key business partners across development, clinical, finance, commercial and business development.


• Influence, negotiate and build alignment among senior cross-functional stakeholders where assumptions, evidence or valuation conclusions are complex, uncertain or contested.


• Develop sensitivity and scenario analyses to characterise key forecast drivers and key risks for senior leadership


• Develop clear summaries of model outputs, conclusions and implications for decision making and present to senior leadership


• Drive delivery of the corporate valuation, ensuring assumptions are robust, well-evidenced and clearly documented


• Support Investor Relations with guidance on sales forecasts for external communication

Inform company-level strategy through forecasting and valuation insight

• Lead complex cross-functional forecasting, valuation and portfolio planning initiatives, coordinating senior stakeholders and driving alignment on key business decisions.


• Develop comparative valuation analyses that position Immunocore’s portfolio against competitors to inform portfolio decisions and the external valuation narrative


• Apply valuation metrics in portfolio-level scenario planning, quantifying the trade-offs between investment options to inform prioritisation and resource allocation decisions


• Support Business Development by valuing licensing and partnering opportunities and outlining key sensitivities


• Establish and maintain best-practice methodologies, governance and quality standards for forecasting and valuation activities


• Lead the continued evolution of the forecasting and valuation platform, improving the approach and tools, in line with the agreed analytics strategy


• Identify, evaluate and implement AI and other novel tools and data sources to build more complex models in less time, improve forecast accuracy and automate routine analyses, freeing capacity for higher-value strategic work


• Act as internal champion for forecasting and valuation methods — validating outputs, defining where AI-assisted analysis is and is not appropriate, building stakeholder confidence in the results, and sharing best practice with colleagues across Portfolio Strategy and partner functions

Inform portfolio strategy projects and deliver CI insights to drive strategy decisions for pipeline products, as required

• Scope and deliver market opportunity assessments for pipeline assets and / or new indications


• Synthesise competitor and clinical data to define current and potential future treatment landscape and clearly identify implications for Immunocore


• Develop and present recommendations to senior leadership on Immunocore’s R&D pipeline, TPP requirements and cross-portfolio strategy decisions to directly influence portfolio prioritisation, clinical investment decisions, corporate valuation and long-term company value creation.


• Deliver Competitive Intelligence CI insights to drive strategy decisions for pipeline assets, as required


• Analyse and track companies, products, and technology platforms within defined focus area(s), taking accountability for CI agenda and deliverables in that area


• Translate detailed competitor analysis into clear and concise summaries and implications, ensuring all outputs are evidence-based and underpinned by thorough analysis


• Undertake deep dives on specific topics as required to inform strategy development and provide real-time updates on key competitor developments

Education, Experience and Knowledge

• Bachelor’s degree in life sciences & 14+ years of relevant experience or equivalent experience


• Relevant experience in biotech / pharma required, via industry, banking, or consultancy roles


• Experience in oncology essential; experience in additional disease areas (e.g. infectious diseases, autoimmune) also desirable


• Business or financial qualification an advantage but not essential


• Excellent analytical abilities, including experience performing very complex competitor and market opportunity analysis in the biopharma industry


• High level of financial literacy, including the ability to build DCF-valuation models and to design new modelling approaches where no precedent exists


• Ability to collate and structure data from multiple sources to form a clear narrative and distil key issues


• Strong understanding of the pharma/biotech industry – technical, clinical, and commercial knowledge


• Highly familiar with technical materials (e.g. scientific publications and clinical manuscripts)


• Strong communication skills – ability to present analysis and justify assumptions to senior leadership, and to influence, negotiate and persuade on difficult and contested concepts


• Strong project management abilities; able to manage multiple workstreams simultaneously in a fast-paced environment


• Experience contributing to company-level strategy, corporate valuation, investor relations and/or business development activity


• Track record of improving processes, tools or platforms, including adoption of new technologies (e.g. AI-enabled modelling and analysis)

About the Company

Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in oncology, infectious diseases and autoimmune disease. Our leaders in R&D are internationally recognised as some of the biotech industry’s most successful drug developers. We are creating not just an environment where great minds can interact but an innovation powerhouse answering the big questions.

Focused on delivering first-in-class biological therapies to patients, we have developed a highly innovative soluble TCR platform. Our ImmTAX molecules underpin a new generation of precision engineered drugs that harness the immune system to treat a broad spectrum of diseases with high unmet medical need, including oncology, infectious diseases and autoimmune diseases.

At Immunocore, we recognize that our employees are our greatest asset. We value the unique contributions each person brings to our team. By embracing Science, Trust, Respect, Integrity, Diversity, and Entrepreneurship (STRIDE), we create an environment where collaboration thrives, ideas flourish, and transformative changes happen. STRIDE represents more than just letters; it embodies our shared identity and drives our mission. We are dedicated to developing breakthrough therapies that transform patients’ lives, advancing medicine, and supporting one another in these pursuits.

Immunocore is proud to be an equal opportunity employer. As such, we are committed to fostering an inclusive workplace where everyone feels valued, respected, and empowered. We encourage applications from individuals of all backgrounds, regardless of race, color, religion, sex, sexual orientation, gender identity or expression, pregnancy, age, national origin, disability status, or any other characteristic protected by law.